AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 52 filers reported holding AVROBIO INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $179,079,000 | -37.2% | 32,093 | 0.0% | 0.00% | – |
| Q2 2021 | $285,307,000 | -91.8% | 32,093 | -88.2% | 0.00% | -100.0% |
| Q1 2021 | $3,461,617,000 | -8.6% | 272,783 | +0.4% | 0.00% | 0.0% |
| Q4 2020 | $3,789,087,000 | -1.9% | 271,814 | -8.4% | 0.00% | 0.0% |
| Q3 2020 | $3,863,073,000 | -23.9% | 296,703 | +2.0% | 0.00% | -33.3% |
| Q2 2020 | $5,077,653,000 | +18.7% | 290,983 | +5.9% | 0.00% | 0.0% |
| Q1 2020 | $4,277,132,000 | +24.5% | 274,880 | +61.1% | 0.00% | +50.0% |
| Q4 2019 | $3,434,943,000 | +65.2% | 170,638 | +15.9% | 0.00% | +100.0% |
| Q3 2019 | $2,079,495,000 | -13.2% | 147,273 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $2,394,659,000 | -28.0% | 147,273 | -2.4% | 0.00% | 0.0% |
| Q1 2019 | $3,325,537,000 | +30.1% | 150,818 | -1.8% | 0.00% | 0.0% |
| Q4 2018 | $2,556,341,000 | -59.8% | 153,534 | +25.4% | 0.00% | -60.0% |
| Q3 2018 | $6,352,311,000 | +90.1% | 122,466 | +4.7% | 0.01% | +66.7% |
| Q2 2018 | $3,341,520,000 | – | 117,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 4,001,627 | $6,162,506 | 5.66% |
| Vazirani Asset Management LLC | 468,273 | $721,140 | 1.10% |
| Atlas Venture Life Science Advisors, LLC | 4,541,381 | $6,993,727 | 1.08% |
| Terrapin Asset Management, LLC | 558,787 | $860,532 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 3,512,686 | $5,409,536 | 0.76% |
| Newtyn Management, LLC | 2,000,000 | $3,080,000 | 0.76% |
| Aldebaran Capital, LLC | 470,130 | $724,000 | 0.74% |
| Aisling Capital Management LP | 1,009,779 | $1,555,060 | 0.64% |
| Western Standard LLC | 310,361 | $477,956 | 0.43% |
| Affinity Asset Advisors, LLC | 500,000 | $770,000 | 0.22% |